Most Popular in:
Peptides: Ready for Primetime?
By: Ahmed Abdullah, MD, FACS
Posted: June 28, 2011, from the July 2011 issue of Skin Inc. magazine.
page 3 of 7
Matrixyl 3000. Peptides are also used in combination, as in the case of Matrixyl 3000. Manufactured by Sederma, Matrixyl 3000 is a combination of palmitoyl oligopeptide and palmitoyl tetrapeptide-7. Together, these peptides are reported to decrease wrinkle density, volume and depth.11
Although chemists have found ways to optimize peptides for use in topical skin care formulations, they still face hurdles before they can generate the results anticipated by the consumers who buy them. Assuming the peptide has been modified to improve its stability in skin care formulations, through chemistry, the use of appropriate product packaging and its ability to penetrate the skin, it’s still essential that the product feature an effective delivery system to reach the target area where collagen synthesis, wound-healing and other activities may occur. Only when the peptide is absorbed by the skin and delivered to the targeted area in a stable form will it stand the potential of generating results.1
Formulators are certainly rising to this challenge. Sophisticated new delivery systems are regularly being developed, and the onus is on skin care professionals to stay on top of these new developments to ensure the products they are recommending stand a strong chance of truly providing their marketed benefits.
Another challenge: To be effective, peptides must be utilized in appropriate concentrations. Unfortunately, ingredient concentrations within a formulation are rarely disclosed on the label. Given the generally high cost of peptides, some manufacturers use them in concentrations below those utilized in scientific research or recommended by the peptide manufacturer. This is a marketing trick that allows the company to tout the use of a certain peptide and charge a lower price for the product. However, the formulation is nearly certain to be ineffective. Because of this, it is important to request and obtain backup research for product claims from manufacturers.
Speaking of research, although some third-party studies do exist that demonstrate positive outcomes from the use of peptides in skin care, there remains the issue of consumer expectations. For example, acetyl hexapeptide-8 is incapable of delivering results similar to that of botulinum toxin injections. Yet, this mantra is still promoted by many consumers and even individuals within the industry when referring to this compound. Because of this, consumer expectations are often out of line with the true capabilities of some peptide products. To be clear, if peptides were indeed able to produce results that matched much of the hype, they would be classified as drugs and require U.S. Food and Drug Administration (FDA) approval for use. To that point, it’s often necessary to downplay much of the hype surrounding the use of these ingredients until a stronger base of unbiased research exists.